Clinical Trial Update: End of EXTEND: Discontinuation of Medication for Patients With Immune Thrombocytopenia

View source ↗

Summary

The EXTEND trial for Immune Thrombocytopenia has terminated and the medication is being discontinued for participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Immune Thrombocytopenia | Status: TERMINATED